Eradicating polio: A balancing act

Affiliations

¹ M. P. Chumakov Institute of Poliomyelitis and Viral Encephalitides, Moscow, 142782, Russia. A. N. Belozersky Institute of Physical-Chemical Biology, M. V. Lomonosov Moscow State University, Moscow, 119899, Russia.
² Department of Molecular Genetics and Microbiology, School of Medicine, Stony Brook University, Stony Brook, NY 11794, USA.
³ Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20903, USA. Konstantin.Chumakov@fda.hhs.gov.
⁴ NIAID, NIH, Bethesda, MD 20892, USA.

Comment

Vadim Agol et al. Science. 2016.

. 2016 Jan 22;351(6271):348.

doi: 10.1126/science.351.6271.348-b.

¹ M. P. Chumakov Institute of Poliomyelitis and Viral Encephalitides, Moscow, 142782, Russia. A. N. Belozersky Institute of Physical-Chemical Biology, M. V. Lomonosov Moscow State University, Moscow, 119899, Russia.
² Department of Molecular Genetics and Microbiology, School of Medicine, Stony Brook University, Stony Brook, NY 11794, USA.
³ Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20903, USA. Konstantin.Chumakov@fda.hhs.gov.
⁴ NIAID, NIH, Bethesda, MD 20892, USA.

No abstract available

Comment on

Eradicating polio.
Adams A, Salisbury DM. Adams A, et al. Science. 2015 Nov 6;350(6261):609. doi: 10.1126/science.aad7294. Science. 2015. PMID: 26542542 No abstract available.